Brentuximab vedotin as consolidation after hematopoietic cell transplant for relapsed Hodgkin lymphoma in pediatric patients

Saved in:
Bibliographic Details
Published inPediatric blood & cancer Vol. 66; no. 12; pp. e27962 - n/a
Main Authors Flerlage, Jamie E., Buttlar, Xinyu, Krasin, Matthew, Triplett, Brandon, Kaste, Sue C., Metzger, Monika L.
Format Journal Article
LanguageEnglish
Published United States 01.12.2019
Subjects
Adolescent
Adult
Antineoplastic Agents, Immunological - therapeutic use
Brentuximab Vedotin - therapeutic use
Consolidation Chemotherapy
Female
Follow-Up Studies
Hematopoietic Stem Cell Transplantation - methods
Hodgkin Disease - drug therapy
Hodgkin Disease - therapy
Humans
Male
Remission Induction
Retrospective Studies
Salvage Therapy
Treatment Outcome
Young Adult
Online AccessGet full text

Cover

More Information
Bibliography:J. E. Flerlage and X. von Buttlar are co‐first authors and both contributed equally to this work.
SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:1545-5009
1545-5017
DOI:10.1002/pbc.27962